CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.06B
1-Year Est. Return 31.81%
This Quarter Est. Return
1 Year Est. Return
+31.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
501
New
Increased
Reduced
Closed

Top Buys

1 +$6.59M
2 +$4.62M
3 +$3.73M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.6M
5
TMUS icon
T-Mobile US
TMUS
+$2.35M

Top Sells

1 +$17.4M
2 +$12.2M
3 +$11.5M
4
AMZN icon
Amazon
AMZN
+$8.86M
5
AVGO icon
Broadcom
AVGO
+$8.43M

Sector Composition

1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
426
SPDR S&P Biotech ETF
XBI
$6.46B
$42.1K ﹤0.01%
508
-7,514
INBX icon
427
Inhibrx
INBX
$852M
$41.5K ﹤0.01%
2,907
+3
YMAB
428
DELISTED
Y-mAbs Therapeutics
YMAB
$41K ﹤0.01%
9,097
+113
ACIU icon
429
AC Immune
ACIU
$361M
$40.9K ﹤0.01%
20,167
+330
CDXS icon
430
Codexis
CDXS
$235M
$40.6K ﹤0.01%
16,639
+23
SCPH
431
DELISTED
scPharmaceuticals
SCPH
$40.4K ﹤0.01%
10,603
+566
ESPR icon
432
Esperion Therapeutics
ESPR
$672M
$39.2K ﹤0.01%
39,808
+286
DSGN icon
433
Design Therapeutics
DSGN
$397M
$38.4K ﹤0.01%
11,402
+45
CRGX
434
DELISTED
CARGO Therapeutics
CRGX
$38.2K ﹤0.01%
9,262
+30
LRMR icon
435
Larimar Therapeutics
LRMR
$371M
$37.2K ﹤0.01%
12,860
+61
EDIT icon
436
Editas Medicine
EDIT
$292M
$37K ﹤0.01%
16,813
+255
OMER icon
437
Omeros
OMER
$525M
$35.3K ﹤0.01%
11,768
+144
VYGR icon
438
Voyager Therapeutics
VYGR
$267M
$34.6K ﹤0.01%
11,114
+157
FDMT icon
439
4D Molecular Therapeutics
FDMT
$573M
$34.5K ﹤0.01%
9,304
+17
ENTA icon
440
Enanta Pharmaceuticals
ENTA
$303M
$32.5K ﹤0.01%
4,293
+14
ALEC icon
441
Alector
ALEC
$152M
$28.1K ﹤0.01%
20,083
+208
LXEO icon
442
Lexeo Therapeutics
LXEO
$708M
$26.8K ﹤0.01%
6,667
+35
KYTX icon
443
Kyverna Therapeutics
KYTX
$338M
$26.6K ﹤0.01%
8,680
+21
VGT icon
444
Vanguard Information Technology ETF
VGT
$114B
$26.5K ﹤0.01%
40
+21
LYEL icon
445
Lyell Immunopharma
LYEL
$331M
$26.2K ﹤0.01%
2,966
+36
FATE icon
446
Fate Therapeutics
FATE
$179M
$25.8K ﹤0.01%
23,024
+179
ALGN icon
447
Align Technology
ALGN
$9.83B
$25.2K ﹤0.01%
133
NMRA icon
448
Neumora Therapeutics
NMRA
$436M
$23.8K ﹤0.01%
32,486
+80
NKTX icon
449
Nkarta
NKTX
$167M
$23.7K ﹤0.01%
14,252
+97
IRWD icon
450
Ironwood Pharmaceuticals
IRWD
$265M
$23.3K ﹤0.01%
32,501
+402